Publicacions
-
Federico A, Gopisetty A, Surdez D, Iddir Y, Autry RJ, Waterfall JJ, Saberi-Ansari E, Bobin C, Ballet S, Pierron G, Wierzbinska JA, Schlicker A, Sill M, Volckmann R, Zwijnenburg DA, Mackay A, Zaïdi S, Saint-Charles A, Mack N, Schwalm B, Brabetz S, Weiser L, Buchhalter I, Previti C, Böttcher AL, Iradier F, Rief EM, Jones DTW, Witt O, Westermann F, Milde T, Eggert A, Huebener N, Schulte JH, Colombetti S, Chesler L, Tucker ER, Morcavallo A, Lorenzi F, Kovar H, Klusmann JH, Debatin KM, Bomken S, Guttke CD, Hamerlik P, Hattersley MM, Garcia M, Colland F, Strougo A, Aviles P, Zapotocky M, Sumerauer D, Gojo J, Berger W, Lötsch-Gojo D, Schueler J, Girard EJ, Olson JM, Schäfer BW, Wachtel M, Molenaar JJ, Dumevska B, Fernandez Potente E, Jones C, Carcaboso AM, Indersie E, Cairo S, Scotlandi K, Manara MC, Landuzzi L, Di Giannatale A, Gasparini P, Moro M, Gürgen D, Hoffmann J, Marques da Costa ME, Geoerger B, Delattre O, Shields DJ, Caron HN, Vassal G, Stancato LF, Pfister SM, Jäger N, Koster J, Kool M and Schleiermacher G.
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.
CANCER RESEARCH . 86(19): 4755-4771.
-
Zhang L, Wang H, Huang G, Qi X, Carcaboso AM, Wang C, Feng J, Han S, Cheng Z, Ma Z, Yang Y, Xu H, Chen M, Li Y, Zhang X, Cui G, Lyu J, Duan Z, Xu A and Yan C.
The clinical and molecular landscape of thalamic glioma.
NEURO-ONCOLOGY . 28(10): 2417-2434.
-
Balaguer-Lluna L, Resa-Parés C, Brstilo L, Gómez-Caballero A, Baulenas-Farrés M, Mohr J, Hu Y, Aschero MR, Rodríguez A, Botteri G, Rodriguez E, Li-Chen L, Mañogil R, Marino F, Martinez N, Ruano A, García-Pelayo Á, Giron A, Mora J, Lavarino C, Sánchez-Navarro M, Teixidó M, Ormazabal-Herrero A, Artuch-Iriberri R, Unceta N, Schaiquevich P and Carcaboso AM.
CNS distribution and preclinical activity of the PI3K/AKT inhibitors inavolisib and ipatasertib in pediatric-type diffuse high-grade gliomas
CANCER CHEMOTHERAPY AND PHARMACOLOGY . 96(1): .
-
Carroué M, Happernegg E, Perrot F, Boucau MC, Dehouck L, Sevin E, Arcicasa M, Balsamelli J, Shimizu F, Kanda T, Carcaboso AM, Toillon RA, Culot M, Meignan S, Gosselet F and Mysiorek C.
Consequences of irradiation on blood-brain tumor barrier model of Diffuse Midline Glioma: characterization of physical and metabolic properties
Fluids and Barriers of the CNS . 23(1): . Nº de cites: 2
-
Schoonbeek MC, Gestraud P, Vernooij L, Boltjes A, Amo-Addae V, van Luik M, Del Nery E, Bellini A, Chua E, Swaak S, Looze EJ, Pietiäinen VM, Turunen LL, Saarela JS, Schueler J, Indersie E, Gürgen D, Scotlandi K, Eggert A, Bouarich R, Bourdeaut F, Zaidi S, Surdez D, Carcaboso AM, Geoerger B, Iddir Y, Saint-Charles A, Saberi-Ansari E, Cavalli F, Gopisetty A, Rief EM, Caron HN, Stancato L, Vassal G, Pfister S, Koster J, Eising S, van Hooff SR, van den Boogaard ML, Schleiermacher G and Molenaar JJ.
Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.
npj Precision Oncology . 10(1): 246. Nº de cites: 2
-
Boult, JKR, Carvalho, DM, Kessler, K, Molinari, V, Mackay, A, Grabovska, Y, Fofana, M, Taylor, KR, Bjerke, L, Fernandez, E, Pereira, R, Clarke, M, Temelso, S, Burford, A, Sejdiu, D, Carcaboso AM, Cockle, JV, Carceller, F, Marshall, LV, Vaidya, SJ, Bridges, LR, Singh, N, Stapleton, S, Hettige, S, Al-Sarraj, S, Reisz, Z, Zebian, B, Bleil, C, Grundy, RG, Gray, JC, Hargrave, D, Wilson, S, Picton, S, Adamski, JK, Hassall, TEG, Mastronuzzi, A, Carai, A, Benjamin, P, Colafati, GS, Vinci, M, Jones, C and Robinson, SP.
Characterization of patient-derived site-specific in vivo models of pediatric-type diffuse high-grade glioma using magnetic resonance imaging
Neuro-Oncology Advances . 8(1): .
-
Saint-Charles A, Masliah-Planchon J, Saberi-Ansari E, Bellini A, Bernkopf M, Font de Mora J, Salvá RN, Van Roy N, Goodman A, Vicha A, Attignon V, Combaret V, Beiske K, Martinsson T, Schoumans J, Rossing M, Tops B, Westermann F, Cotteret S, Fischer M, Birger Y, Mazzocco K, Chesler L, Betts D, Cowley M, Capasso M, Bobin C, Iddir Y, Zaidi S, Carcaboso AM, Vandermeulen J, Loontiens S, Gaarder J, Ibrahim RR, Rosswog C, Hameiri-Grossman M, Shichrur K, Trahair T, Barahona P, Eggert A, Deubzer HE, Delattre O, Pasqualini C, George S, Tytgat G, Tweddle DA, Taschner-Mandl S and Schleiermacher G.
Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma A SIOPEN Biology Study
JOURNAL OF MOLECULAR DIAGNOSTICS . 28(1): 27-38.
-
Vardon A, Haston S, Hamdi H, Cooksley G, Guiho R, Carvalho D, Carter R, Boult JKR, Gharai D, Cloete I, Grey J, Apps J, Zhou D, Zheng G, Martínez-Máñez R, Lythgoe MF, Donovan LK, Carcaboso AM, Williams O, Hong Y, Alexandre P, Gil J, Dean JA, Michod D, Jones C, Hargrave D and Martinez-Barbera JP.
Navitoclax acts synergistically with irradiation to induce apoptosis in preclinical models of H3K27M-altered diffuse midline glioma
Scientific Reports . 15(1): 45094-45094. Nº de cites: 2
-
Prada-Varela E, Táboas-Outón P, Andrades E, Gomez-Gonzalez S, Mateo-Lozano S, Cebrià A, Berenguer-Molins P, Perera-Bel J, Arcon JP, Saen-Oon S, Díaz L, Gay M, Folch-I-Casanovas I, Odena A, Vilaseca M, Rovira Q, García-Gerique L, Rodriguez E, Rovira-Zurriaga C, Rodrigues G, Carcaboso AM, Avgustinova A, Hernandez-Muñoz MI and Mora J.
PRKG1 hinders myogenic differentiation and predicts response to AKT inhibitor ipatasertib in Rhabdomyosarcoma
Nature Communications . 16(1): 9816-9816. Nº de cites: 2
-
Olmedo-Pelayo J, Granado-Calle E, Delgado-Bellido D, Lobo-Selma L, Jordan-Perez C, Monteiro-Amaral AT, Ehlers AC, Ohmura S, Garcia-Dominguez DJ, Mackintosh C, Carcaboso AM, Alonso J, Machado I, Llombart-Bosch A, Scotlandi K, Grünewald TGP, Gomez-Herreros F and de Alava E.
EWS::FLI1-DHX9 interaction promotes Ewing sarcoma sensitivity to DNA topoisomerase 1 poisons by altering R-loop metabolism
ONCOGENE . 44(38): 3537-3552. Nº de cites: 4
